No Data
No Data
BioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
bioAffinity Technologies, Inc. (NASDAQ:BIAF) today announced it has closed a securities purchase agreement with institutional investors for the purchase and sale of 1,600,000 shares of common stock in a registered
BioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
bioAffinity Technologies, Inc. (NASDAQ:BIAF) today announced it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 1,600,000 shares of common stock in a registered
Here's Why We're A Bit Worried About BioAffinity Technologies' (NASDAQ:BIAF) Cash Burn Situation
BioAffinity Technologies News Update
bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease, provides a summary of recent Company
Medical Director of Pennsylvania's Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins BioAffinity Technologies' Medical and Scientific Advisory Board and Incorporates CyPath Lung Into Medical Practice
Lung Innovations Network, a patient-centered practice that offers comprehensive lung care to over 10,000 patients in central and western Pennsylvania, will incorporate CyPath Lung into its practice to aid in the detection of early-stage lung cancer.
BioAffinity Technologies Appoints Jamie Platt, Ph.D., to Its Board of Directors
bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease, today announced the appointment of Jamie
No Data